Biotechnology · San Diego, California, United States
$7.88
+0.51% (+$0.04)2026-07-10
Smart-Money SignalNeutral · 53/100— Insiders are net sellers over 90 days (-$246K, 3 sales vs 3 buys)
Revenue$22.7M
Net Income-$60.6M
EPS$-0.61
Market Cap$782.5M
Price Performance
Historical data including institutional events
Company Profile
R
Richard Lowenthal
CEO & Executive Director
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis.
ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
